Soligenix, Inc. is a late-stage biopharmaceutical company focused on developing and commercializing products for rare diseases with unmet medical needs. It operates two segments: Specialized BioTherapeutics (HyBryte for CTCL, SGX302 for psoriasis, dusquetide for Behcet's Disease and oral mucositis) and Public Health Solutions (RiVax ricin vaccine, SGX943 for infectious disease, filovirus vaccines, CiVax for COVID-19), leveraging its proprietary ThermoVax heat stabilization platform with government funding support.
expected 2026-12-21
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-31 | 2025-12-31 | 0001104659-26-037701 | EDGAR | 75K words |
| 2025-03-21 | 2024-12-31 | 0001558370-25-003459 | EDGAR | 78K words |
| 2024-03-15 | 2023-12-31 | 0001558370-24-003402 | EDGAR | 77K words |
| 2023-03-31 | 2022-12-31 | 0001558370-23-005304 | EDGAR | 73K words |
| 2022-03-29 | 2021-12-31 | 0001558370-22-004605 | EDGAR | — |
| 2021-03-30 | 2020-12-31 | 0001213900-21-018698 | EDGAR | — |
| 2020-03-30 | 2019-12-31 | 0001213900-20-007959 | EDGAR | — |
| 2019-03-26 | 2018-12-31 | 0001213900-19-004865 | EDGAR | — |
| 2018-03-15 | 2017-12-31 | 0001213900-18-003007 | EDGAR | — |
| 2017-03-27 | 2016-12-31 | 0001213900-17-002845 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-07 | 2026-06-30 | 0001104659-26-092681 | EDGAR | 28K words |
| 2025-11-07 | 2025-09-30 | 0001104659-25-108475 | EDGAR | 30K words |
| 2025-08-14 | 2025-06-30 | 0001558370-25-011554 | EDGAR | 30K words |
| 2025-05-09 | 2025-03-31 | 0001558370-25-007171 | EDGAR | 38K words |
| 2024-11-08 | 2024-09-30 | 0001558370-24-015054 | EDGAR | 33K words |
| 2024-08-09 | 2024-06-30 | 0001558370-24-011740 | EDGAR | 34K words |
| 2024-05-10 | 2024-03-31 | 0001558370-24-007782 | EDGAR | 31K words |
| 2023-11-13 | 2023-09-30 | 0001558370-23-018818 | EDGAR | 39K words |
| 2023-08-21 | 2023-06-30 | 0001558370-23-015144 | EDGAR | 40K words |
| 2023-05-15 | 2023-03-31 | 0001558370-23-009929 | EDGAR | 34K words |
| 2022-11-10 | 2022-09-30 | 0001558370-22-017406 | EDGAR | 31K words |
| 2022-08-12 | 2022-06-30 | 0001558370-22-013491 | EDGAR | 30K words |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-09-21 | 0001104659-26-109329 | EDGAR | 2K words |
| 2026-02-12 | 0001104659-26-014267 | EDGAR | 1K words |
| 2026-01-23 | 0001104659-26-006233 | EDGAR | 27K words |
| 2025-11-18 | 0001104659-25-113645 | EDGAR | 1K words |
| 2025-09-29 | 0001104659-25-094507 | EDGAR | 1K words |
| 2025-08-18 | 0001558370-25-011625 | EDGAR | 2K words |
| 2025-08-15 | 0001558370-25-011619 | EDGAR | 1K words |
| 2025-07-31 | 0001104659-25-072708 | EDGAR | 2K words |
| 2025-06-20 | 0001558370-25-008772 | EDGAR | 9K words |
| 2025-03-28 | 0001558370-25-003987 | EDGAR | 11K words |
338 total filings indexed. 306 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0000812796 |
| Ticker | SNGX |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Headquarters | Princeton, New Jersey |
| Website | https://www.soligenix.com |
| Listed | 1994-04-05 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/SNGX (~200 tokens, structured JSON with cryptographic provenance)